The Liver Meeting 2020-Hepatitis C SIG Paving the Road to Hepatitis C Elimination

Video Transcription

Video Summary

Dr. John Ward discusses the global aim of eliminating Hepatitis C Virus (HCV) by 2030, stressing the importance of widespread all-adult testing to reduce mortality and incidents. Successful HCV elimination programs in Egypt, Punjab State, and Rwanda exemplify the impact of community involvement and scaling up testing. Dr. Ward emphasizes factors like stakeholder engagement, funding, and data systems for effective micro-elimination efforts. Challenges such as COVID-19 are acknowledged, but the focus remains on addressing care gaps to reach global HCV elimination targets.<br /><br />Dr. Stacey Truskin shares insights on addressing HCV in persons who inject drugs and the importance of community involvement for micro-elimination. The transcript highlights successful HCV-positive organ transplants with high cure rates using direct-acting antivirals, emphasizing the need for informed consent, treatment regimens, and insurance coverage for successful outcomes post-transplant.<br /><br />The video underscores the importance of utilizing HCV-positive organs for transplants to expand options, save lives, and optimize resource use. Addressing disparities, potential risks, and ensuring patient consent and optimal treatment regimens are crucial for successful implementation of such transplants.

Keywords

Hepatitis C Virus

HCV

global aim

elimination

testing

community involvement

micro-elimination

stakeholder engagement

funding

data systems

COVID-19 challenges

organ transplants

direct-acting antivirals